drugset / Trial / NCT00258141

Study With Rupatadine in Mosquito-Bite Allergic Adult Subjects

NCT00258141 ↗

Phase 4 Unknown 30 enrolled J. Uriach and Company
RandomizedCrossoverDouble-blindPrevention

Summary

The study will find out how effective rupatadine is in the treatment of mosquito bite symptoms in adult patients allergic to mosquito bites.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Rupatadine Small molecule 10 mg —

Indications